Research Output per year
Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717-454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitorSikaria, S., Heim-Hall, J., Diaz, E. H., Williams, R., Sankhala, K., Laabs, B. & Mita, M., Mar 2014, In : Targeted Oncology. 9, 1, p. 73-79 7 p.
Research output: Contribution to journal › Article
10/1/15 → 10/2/15
36 items of Media coverage
Press/Media: Press / Media